CNS tumours
CNS tumours: Invited Discussant 325O and 326O
Date
08 Sep 2017Session
CNS tumoursPresenters
Martin van den BentAuthors
M.J. van den BentAuthor affiliations
- Neuro-oncology, Erasmus MC Daniel den Hoed Cancer Center, 3075 EA - Rotterdam/NL
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
5125 - Meta-analysis Of The Effect Of Rituximab İn The Treatment Of Primary Central Nervous System Lymphoma
Presenter: Sinan Yavuz
Session: CNS tumours
Resources:
Abstract
4070 - Tumor Treating Fields (TTFields) – A novel cancer treatment modality: Translating preclinical evidence and engineering into a survival benefit with delayed decline in quality of life
Presenter: Roger Stupp
Session: CNS tumours
Resources:
Abstract
4943 - Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly-diagnosed glioblastoma
Presenter: Maxime Fontanilles
Session: CNS tumours
Resources:
Abstract
4169 - Treatment of Recurrent Glioblastoma (GB) after Radiotherapy (RT) and Temozolomide (TMZ): A retrospective analysis of the GLIOCAT study
Presenter: Miguel Gil
Session: CNS tumours
Resources:
Abstract
CNS tumours: Invited discussant 333PD, 334PD, 335PD and 336Pd
Presenter: Joerg-Christian Tonn
Session: CNS tumours
Resources:
Slides
Webcast
CNS tumours: Invited Discussant 329PD, 330PD, 331PD and 332PD
Presenter: Pim French
Session: CNS tumours